Phase 2 COMBINE programme launched

Following the success of the first phase of the COMBINE coordinated assessment programme, which permitted the assessment of combined studies through the Clinical Trials Information System (CTIS), the European Commission and EU Member States have launched a second phase of the programme. Phase 2, which is expected to remain open for at least one year, expands the scope of studies eligible to participate, introducing a more agile, rolling process with monthly slots for the submission of expressions of interest.